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The adherence protein (P1 protein) of Mycoplasma pneumoniae was purified by electroelution and cleaved
with cyanogen bromide. The resulting peptides were separated by two-dimensional electrophoresis. Spots
reacting in Western immunoblots with two attachment-inhibiting monoclonal antibodies were isolated, and the
amino4erminal ends of these peptides were microsequenced. The two monoclonal antibodies had different
binding sites. One was associated with the amino-terminal region of the whole P1 protein beginning at amino
acid position 237, and the other was associated with amino acid position 702, which was localized
approximately in the middle of the P1 amino acid sequence. Serum samples from three M. pneumoniae-infected
patients were tested by Western blotting against the cyanogen bromide peptide pattern. All three serum
samples reacted with peptide fragments beginning at amino acid position 702, but the serum of only one patient
also had antibodies against the oligopeptides beginning at amino acid position 237. These results indicate that
the corresponding epitopes of the P1 protein are also immunogenic if they are presented at the surface of the
infecting organism.
The human pathogen Mycoplasma pneumoniae is able to
bind to surfaces of respiratory cells or erythrocytes. The
binding site of M. pneumoniae has been shown by electron
microscopy to be a surface protein (P1 protein) which is
localized mainly in the tip structure membrane of M. pneu-
moniae cells (1, 4, 6). Monoclonal antibodies (MAbs) react-
ing with this adhesin inhibit the attachment of sheep eryth-
rocytes to M. pneumoniae cell layers grown on plastic
surfaces (12). These surface-exposed epitopes of M. pneu-
moniae membranes are also of special interest for M. pneu-
moniae serology (7, 9, 14), because the sera of most patients
suffering from M. pneumoniae infections contain adherence-
inhibiting antibodies (12). Dallo et al. (2) have identified an
adherence-mediating sequence by screening cloned P1 frag-
ments with an adherence-inhibiting MAb. In this study we
identified two other epitopes on the primary sequence of this
molecule by another approach. The P1 protein was purified
out of M. pneumoniae cells and cleaved with cyanogen
bromide. The oligopeptides were separated two-dimension-
ally and were probed with adherence-inhibiting MAbs. Pep-
tide spots reacting with the antibodies were microse-
quenced, and the resulting amino acid sequences of the
amino termini of these peptides were localized on the P1
molecule, which was recently cloned and sequenced inde-
pendently by Su et al. (19) and Inamine et al. (8). To obtain
information about the immunogenicity of these epitopes
during M. pneumoniae infections, the antibody activities of
patient serum with these peptides were studied.
MATERIALS AND METHODS
Chemical cleavage of the P1 protein. The P1 protein was
isolated out of M. pneumoniae FH as described previously
(10). P1 protein (1 mg) was cleaved for 18 h with cyanogen
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bromide as described by Kamp (13). Cyanogen bromide was
extracted by gel filtration with prepacked PC-10 columns
(Pharmacia, Freiburg, Federal Republic of Germany). The
peptide solution was concentrated by ultrafiltration (cen-
tricon 10 cells; Amicon Corp., Lexington, Mass.) to a 50-,ul
volume.
Peptide separation. Peptide (150 ,ug) was separated by
two-dimensional polyacrylamide gel electrophoresis accord-
ing to the isoelectric point by isoelectric focusing in the first
dimension (pH 3 to 10) and according to the molecular
weight by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis in the second dimension (12% separating gel), as
described by O'Farrell (17).
Epitope mapping. Isolated peptides were blotted to trans-
fer membranes (Immobilon; Millipore Corp., Bedford,
Mass.). The sera of patients suffering from M. pneumoniae
disease or MAbs (62F2 and M-328) with attachment-inhib-
iting activity (12) were tested for antibody reactions with the
peptide fragments by the Western immunoblot method (20).
Gas-phase sequencing of immobilized peptides. Gas-phase
sequencing was performed on peptide spots which were cut
out of transfer membranes and stained with Coomassie blue
(16). The amino-terminal ends of the oligopeptides were
sequenced by Edman degradation in a gas-phase protein
sequencer (477A; Applied Biosystems). Phenylthiohydan-
toin derivates of amino acids were identified by reverse-
phase chromatography as described by Lottspeich (15). The
resulting sequence was localized on the known amino acid
sequence of the P1 protein (8, 19).
MAbs and patient sera. MAbs 62F2 and M-328 (8) (both
immunoglobulin G [IgG]) were selected for activity against
the P1 protein by using an enzyme-linked immunosorbent
assay (ELISA) with purified P1 protein as the antigen and for
adherence-inhibiting activity of sheep erythrocytes to adher-
ent M. pneumoniae cells in microtiter plates as described
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FIG. 1. MAb M-328 (A) and MAb 62F2 (C) show binding with microsequenced peptide fragments (1 to 7) of the cyanogen bromide-cleaved
P1 protein by the Western immunoblot technique after separation of peptide fragments in a two-dimensional electrophoresis, Coomassie
blue-stained peptide pattern (B). Molecular weight markers are indicated to the right of panels B and C (in thousands). Abbreviations: SDS,
Sodium dodecyl sulfate; IEF, immunoelectrofocusing.
previously (11, 12). Paired sera of patients with clinical
symptoms of respiratory diseases and pneumonia were
tested for antibodies to M. pneumoniae by the complement
fixation test, the P1 ELISA, and the adherence-inhibiting
assay (12).
RESULTS
The P1 protein fragments obtained by cyanogen bromide
cleavage were separated by two-dimensional electrophore-
sis. The fingerprints of Coomassie blue-stained peptides
immobilized on transfer membranes are shown in Fig. lB.
To localize the MAb-binding sites on the P1 protein amino
acid sequence, the N termini of peptide fragments with the
lowest molecular weights were selected for microsequenc-
ing. Of these peptide spots, the N-terminal ends of peptide
fragments 1 to 7 could be sequenced. MAb M-328 bound to
peptide fragment 1 (Fig. 1A), which had an approximate
Asn(60) P
N-( 1)Met




FIG. 2. Location of MAb-binding regions on the primary amino
acid sequence of the P1 protein (MAb 62F2: N-[237 amino acids]-
Phe; MAb M-328: N-[702 amino acids]-Trp). The whole P1 protein
amino acid sequence with the precursor region of 59 amino acids
beginning with N-(1 amino acid)-Met and the mature P1 protein
beginning with N-(60 amino acids)-Asn are as described previously
(8, 19). Predicted hydrophilic (P) and hydrophobic (A) surface
protein sequences according to hydrophilic and hydrophobic plots
are as described by Hopp and Woods (5) and Eisenberg et al. (3).
molecular weight of 20,000 (about 160 amino acids), and
peptide fragments 5, 6, and 7, which each had a molecular
weight of approximately 30,000 (about 250 amino acids).
Microsequencing analysis of these four different peptides
showed a common amino terminus of (N)WAWQVYN
WSN. This sequence was localized in the middle of the P1
protein beginning at amino acid position 702 (Fig. 2). The
second MAb, 62F2, bound to peptide fragments 2, 3, and 4
(Fig. 1C), which each had a molecular weight of approxi-
mately 25,000 (about 210 amino acids). Likewise, these
peptides, possessed a common amino terminus beginning
with (N)FGLKVKNAEA. This sequence was identical to a
sequence near the amino terminus of the mature P1 protein
starting at amino acid position 237 (Fig. 2).
To find out whether these attachment sites containing
peptide fragments were immunogenic during M. pneumoniae
diseases, serum samples from three patients suffering from
M. pneumoniae infection with significant antibody rises in
the complement fixation test and in the P1 protein ELISA
and with increasing adherence-inhibiting antibodies were
tested for IgG activity (Table 1). The second serum samples
(reconvalescent phase) from all three patients reacted with
peptide fragments 1, 5, 6, and 7 (Fig. 3B, C, and D) and were
identical to the binding site of MAb M-328. One serum
sample also recognized peptide fragments 2, 3, and 4, which
were the binding sites of MAb 62F2 (Fig. 3D).
DISCUSSION
Studies about the relation between the structure and
function of the P1 membrane protein are now possible
because (i) the amino acid sequence is known (8, 19), (ii) the
protein has been isolated (10), and (iii) MAbs especially
directed to the attachment epitopes have been established in
several laboratories (1, 4, 6).
TABLE 1. Paired sera of three patients suffering from M. pneumoniae disease tested for antibody activity in the complement fixation
test; in the P1 protein ELISA for IgG, IgM, and IgA; and for adherence-inhibiting antibodies
Patient age Time (days) after Complement fixation P1 ELISA titer-' Adherence-inhibiting
(yr) Clinical diagnosis onset of symptoms titer-' test IgG IgM IgA antibody titer-
47 Atypical pneumonia 7 10 50 <50 <50 <2
16 240 6,400 3,200 3,200 32
14 Pneumonia 7 10 <50 <50 <50 <2
17 120 800 800 400 8
28 Pneumonia 8 30 50 50 <50 <2
19 240 3,200 400 800 16
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FIG. 3. Binding of IgG in the serum of patients suffering from M. pneumoniae diseases to peptide fragments of the chemically cleaved P1
protein. (A) Coomassie blue-stained peptide fragments after separation by two-dimensional electrophoresis. Different patient serum samples
are given in panels B to D (B, 47-year-old patient; C, 28-year-old patient, D, 14-year-old patient; see Table 1). Molecular weights are given
in thousands. Abbreviations: SDS, Sodium dodecyl sulfate; IEF, immunoelectrofocusing.
Studies on the P1 protein obtained by cloning and expres-
sion in Escherichia coli have been limited until now by the
premature termination of M. pneumoniae proteins in E. coli
because of the presence of UGA codons, which are read as
tryptophan in M. pneumoniae instead of as a termination
codon (2, 18). In our study the whole P1 protein was
therefore isolated out of M. pneumoniae cells and chemi-
cally fragmented to oligopeptides.
The two MAbs with attachment-inhibiting activities
shared binding to different peptide fragments of the cyano-
gen bromide-cleaved P1 protein. Peptide fragments 1 to 7
could be analyzed by the microsequence method that was
used, but the other peptide spots contained too little protein
or the N terminus was blocked. Interestingly, peptide frag-
ments 1, 5, 6, and 7 and peptide fragments 2, 3, and 4
contained two different attachment sites which were local-
ized at quite different positions in the primary sequence of
the P1 protein. According to the analysis of Eisenberg et al.
(3), these two regions are separated by two hydrophobic
sequences with a-helices long enough to theoretically cross
biomembranes. Recently, Dallo et al. (2) showed another
attachment epitope near the C terminus. From these results
one might speculate that the native attachment epitope on
the tertiary structure consists of several surface-exposed
loops.
IgG in the second serum samples (reconvalescent phase)
from all three patients reacted especially with the peptide
fragments recognized by MAb M-328. The serum of only one
patient also developed IgG activity to MAb 62F2 binding
sites. The first serum samples from the same patients
showed only a very faint fingerprint, especially to peptide
fragment 1 (data not shown).
Apparently, during M. pneumoniae diseases the immune
system of infected patients recognizes parts of the P1 protein
which are involved in attachment. However, the peptide
fragments of about 20, 25, and 30 kilodaltons were still too
large to determine whether the attachment epitopes of the
two MAbs and the binding sites of antibodies from patient
sera were identical or whether other regions close to these
attachment epitopes were involved in the antibody re-
sponses of the infected host organism.
Further topographical studies of the native P1 protein may
lead to more detailed knowledge of the functional attach-
ment sites and of the corresponding antigenic epitopes. This
information will be of great importance if synthetic peptides
are used as antigens in an ELISA for M. pneumoniae
serology.
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